Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study

---

Atıf İçin Kopyala

AYDIN N. N., AKSOY F., YAVUZ İ., Iskender S., YILDIRIM A. A., Yildiz I. E., ...Daha Fazla

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.25, sa.3, ss.105-108, 2019 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 25 Sayı: 3
• Basım Tarihi: 2019
• Doi Numarası: 10.4274/vhd.galenos.2019.2019.0025
• Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.105-108
• Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Objectives: Hepatitis C virus (HCV) infection is common among hemodialysis (HD) patients and is associated with increased morbidity and mortality. New generation direct-acting antiviral (DAA) agents are safe and effective in treatment HCV infection in HD patients. The aim of this a multi-center study was to assess the efficacy of DAAs in HD patients with HCV infection.